Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 188

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 188
---
 the application for any patent term extension or restoration. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. In the future, if and when our products receive FDA approval, we expect to apply for patent term extensions on patents covering those products, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted, and if granted, the length of such extensions. See “Risk Factors—Risks Related to Our Intellectual Property.” 113 Legal proceedings We are not currently subject to any material legal proceedings. Employees As of January 21, 2024, our senior management team is comprised of Adi Zuloff-Shani (Chief Executive Officer), Mark Haden (Vice President of Business Development), and Alan Rootenberg (Chief Financial Officer). Beyond our senior management team, we have one additional part-time employee and we engage with various consultants and service provides from time to time, including outsourced research and development providers. All of our employees are located in Israel and Canada. None of our employees are represented by labor unions or covered by collective bargaining agreements. We believe that we maintain good relations with all of our employees. However, in Israel, we are subject to certain Israeli labor laws, regulations and national labor court precedent rulings, as well as certain provisions of collective bargaining agreements applicable to us by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Ministry of Economy and which apply such agreement provisions to our employees even though they are not part of a union that has signed a collective bargaining agreement. All of our employment and consulting agreements include employees’ and consultants’ undertakings with respect to non-competition and assignment to us of intellectual property rights developed in the course of employment and confidentiality. The enforceability of such provisions is limited by Israeli law. Organizational Structure We currently have two (2), wholly-owned subsidiaries, Clearmindmed Ltd., a company incorporated in the State of Israel, and Clearmind Labs Corp., incorporated in Canada. Property, Plant and Equipment Our registered offices are located at 101 – 1220 West 6th Avenue Vancouver, British Columbia V6H1A5 and our principal executive offices are located at 20 Raoul Wallenberg St Tel-Aviv, 6971916, Israel. On April 1, 2024, we entered into an agreement with Capitalink Ltd. for the lease of office space in Tel Aviv, Israel for our